Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Aria claims the Forest 1 device is the world’s “most advanced” brain-computer interface as it can simultaneously influence ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Now, a new crop of buzzy non-invasive VNS gadgets promises to relieve stress, sharpen focus and improve sleep in mere minutes ...

As technology progresses, watches are now able to accurately measure our sleep, detect heart problems, and even predict when ...

A international joint research team of KAIST and the University of Michigan developed a digital biomarker for predicting ...

The FDA has approved Spravato (esketamine) nasal spray for use as monotherapy for patients with treatment-resistant depression.

Neuralink’s brain-computer interface technology also has been discussed for other potential uses, for example, in mental ...

The general consensus is that LEDs are OK to use in commercial establishments like beauty salons and medical spas, provided ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

Cork medtech company Cergenx has secured the support of US regulators for a device that allows maternity hospital staff to ...